Find a Tender
complete
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Scotland: "NP49124 Hepatitis C Medicines". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Scotland | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Scotland
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Scotland. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
5.4Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 5 active published awards; 5 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Scotland | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published21 Mar 2024, 12:15 GMT | Last source update21 Mar 2024, 12:15 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-041e33 | ||
What is being bought
Supply of Hepatitis C Medicines to NHS Scotland.
What changed
From the official release history
- tender value changed
21 Mar 2024, 12:15 GMT - Status changed to complete
21 Mar 2024, 12:15 GMT - Official notice release published
21 Mar 2024, 12:15 GMT - Submission deadline changed to published date
21 Mar 2024, 12:15 GMT - Published value updated to £35,791,085
1 Dec 2023, 09:00 GMT - Status changed to active
1 Dec 2023, 09:00 GMT - Official notice release published
1 Dec 2023, 09:00 GMT - Submission deadline changed to 12 Jan 2024, 12:00 GMT
1 Dec 2023, 09:00 GMT - Buyer information updated
1 Dec 2023, 09:00 GMT
Lots and requirements (3)
Published by the contracting authority
- Lot 1 · #1Hepatitis C - Treatment Cost per MedicinecancelledPublished valueNot publishedSupply of Hepatitis C Medicines to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Hepatitis C Medicines - Price submitted based on Volume (unscored)cancelledPublished valueNot publishedSupply of Hepatitis C to NHS Scotland to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants. Please note II.2.5) Award criteria is not applicable. This was an unscored Lot. Additional information: Please note II.2.5) Award criteria is not applicable as this is an unscored lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Hepatitis C Medicines - Price submitted based on Volume (unscored)cancelledPublished valueNot publishedSupply of Hepatitis C to NHS Scotland to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants. Please note II.2.5) Award criteria is not applicable. This was an unscored Lot. Additional information: Please note II.2.5) Award criteria is not applicable. This was an unscored Lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
21 Mar 2024, 12:15 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 27 Feb 2024, 00:00 GMT · £36,556,080 - Contract active
Signed 27 Feb 2024, 00:00 GMT · £1 - Contract active
Signed 27 Feb 2024, 00:00 GMT · £1
Commercial outcome and competition
Awards AbbVie Ltd, Gilead Sciences Ltd, Merck Sharp & Dohme UK Ltd Not published · Not published · active AbbVie Ltd, Gilead Sciences Ltd Not published · Not published · active AbbVie Ltd, Gilead Sciences Ltd Not published · Not published · active |
Contracts Hepatitis C - Treatment Cost per Medicine £36,556,080 · signed 27 Feb 2024, 00:00 GMT · active Hepatitis C Medicines - Price submitted based on Volume (unscored) £1 · signed 27 Feb 2024, 00:00 GMT · active Hepatitis C Medicines - Price submitted based on Volume (unscored) £1 · signed 27 Feb 2024, 00:00 GMT · active |
Bid statistics bids: 3 (lot 1) electronicBids: 3 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 3 (lot 1) smeBids: 0 (lot 1) bids: 2 (lot 2) electronicBids: 2 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 2 (lot 2) smeBids: 0 (lot 2) bids: 2 (lot 3) electronicBids: 2 (lot 3) foreignBidsFromEU: 0 (lot 3) foreignBidsFromNonEU: 2 (lot 3) smeBids: 0 (lot 3) |
Buyer and organisations in this procedure
NHS Scotland
Contracting authority GB-FTS-99704Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published